Literature DB >> 16701951

Enhanced neurogenesis in the ischemic striatum following EGF-induced expansion of transit-amplifying cells in the subventricular zone.

Mikiko Ninomiya1, Toru Yamashita, Nobuo Araki, Hideyuki Okano, Kazunobu Sawamoto.   

Abstract

In the subventricular zone (SVZ) of the adult mammalian brain, neural stem cells continually produce transit-amplifying precursors, which generate neuroblasts migrating into the olfactory bulb. Previous studies have suggested that SVZ cells also have the capacity to generate some striatal neurons after cerebral ischemia. The infusion of epidermal growth factor (EGF) has been demonstrated to increase the number of these regenerated neurons. However, which cell types in the SVZ are stimulated to proliferate or differentiate after EGF infusion remains unknown. In this paper, we demonstrated that cerebral ischemia results in an increase in the number of EGF receptor (EGFR)-positive transit-amplifying cells in the SVZ. EGF infusion into the ischemic brain caused the number of transit-amplifying cells to increase and the number of neuroblasts to decrease. On the other hand, after an interval of 6 days after the discontinuation of EGF infusion, a significant increase in the number of neuroblasts was found, both in the striatum and the SVZ. These results suggest that the replacement of neurons in injured striatum can be enhanced by an EGF-induced expansion of transit-amplifying cells in the SVZ.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16701951     DOI: 10.1016/j.neulet.2006.04.039

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

Review 1.  Cell-based therapy for stroke.

Authors:  Yu Luo
Journal:  J Neural Transm (Vienna)       Date:  2010-10-14       Impact factor: 3.575

2.  Regional distribution and cell type-specific subcellular localization of Prothymosin alpha in brain.

Authors:  Sebok Kumar Halder; Hiroshi Ueda
Journal:  Cell Mol Neurobiol       Date:  2011-07-13       Impact factor: 5.046

Review 3.  Neural stem cells: involvement in adult neurogenesis and CNS repair.

Authors:  Hideyuki Okano; Kazunobu Sawamoto
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-06-27       Impact factor: 6.237

4.  Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain.

Authors:  Hiromi Kawai; Toru Yamashita; Yasuyuki Ohta; Kentaro Deguchi; Shoko Nagotani; Xuemei Zhang; Yoshio Ikeda; Tohru Matsuura; Koji Abe
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-10       Impact factor: 6.200

5.  The effect of epidermal growth factor in the injured brain after trauma in rats.

Authors:  Dong Sun; M Ross Bullock; Nabil Altememi; Zhengwen Zhou; Sarah Hagood; Andrew Rolfe; Melissa J McGinn; Robert Hamm; Raymond J Colello
Journal:  J Neurotrauma       Date:  2010-05       Impact factor: 5.269

Review 6.  Neural stem cell therapies and hypoxic-ischemic brain injury.

Authors:  Lei Huang; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2018-05-21       Impact factor: 11.685

Review 7.  Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders.

Authors:  Diana Yu; Gabriel A Silva
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

8.  A novel role of CPEB3 in regulating EGFR gene transcription via association with Stat5b in neurons.

Authors:  Shu-Chun Peng; Yen-Ting Lai; Hsi-Yuan Huang; Hsien-Da Huang; Yi-Shuian Huang
Journal:  Nucleic Acids Res       Date:  2010-07-17       Impact factor: 16.971

Review 9.  Cell migration in the normal and pathological postnatal mammalian brain.

Authors:  Myriam Cayre; Peter Canoll; James E Goldman
Journal:  Prog Neurobiol       Date:  2009-02-11       Impact factor: 11.685

10.  Traumatic brain injury reveals novel cell lineage relationships within the subventricular zone.

Authors:  Gretchen M Thomsen; Janel E Le Belle; Jessica A Harnisch; Whitney S Mc Donald; David A Hovda; Michael V Sofroniew; Harley I Kornblum; Neil G Harris
Journal:  Stem Cell Res       Date:  2014-04-28       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.